KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Short term Debt (2020 - 2025)

Historic Short term Debt for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $45.0 million.

  • Organon's Short term Debt rose 35000.0% to $45.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.0 million, marking a year-over-year increase of 35000.0%. This contributed to the annual value of $20.0 million for FY2024, which is 12222.22% up from last year.
  • According to the latest figures from Q3 2025, Organon's Short term Debt is $45.0 million, which was up 35000.0% from $115.0 million recorded in Q2 2025.
  • In the past 5 years, Organon's Short term Debt ranged from a high of $1.5 billion in Q1 2021 and a low of $8.0 million during Q3 2022
  • In the last 5 years, Organon's Short term Debt had a median value of $9.0 million in 2021 and averaged $100.1 million.
  • As far as peak fluctuations go, Organon's Short term Debt tumbled by 9940.79% in 2022, and later skyrocketed by 117777.78% in 2025.
  • Quarter analysis of 5 years shows Organon's Short term Debt stood at $9.0 million in 2021, then dropped by 11.11% to $8.0 million in 2022, then rose by 12.5% to $9.0 million in 2023, then soared by 122.22% to $20.0 million in 2024, then soared by 125.0% to $45.0 million in 2025.
  • Its last three reported values are $45.0 million in Q3 2025, $115.0 million for Q2 2025, and $20.0 million during Q1 2025.